CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
The CXCR4 Antagonist AMD3100 Has Dual Effects on Survival and Proliferation of Myeloma Cells In Vitro
Ha-Yon Kim, Ji-Young Hwang, Seong-Woo Kim, Hyo-Jin Lee, Hwan-Jung Yun, Samyong Kim, Deog-Yeon Jo
Cancer Research and Treatment. 2010;42(4):225-234.   Published online 2010 December 31    DOI: https://doi.org/10.4143/crt.2010.42.4.225

Excel Download

The CXCR4 Antagonist AMD3100 Has Dual Effects on Survival and Proliferation of Myeloma CellsIn Vitro
Cancer Research and Treatment. 2010;42(4):225   Crossref logo
Link1 Link2

The CXCR4 antagonist Plerixafor (AMD3100) promotes Ewing sarcoma cell survival and migration in Ewing sarcoma cells in vitro
European Journal of Cancer. 2016;69:S50   Crossref logo
Link1 Link2

The Dual Effect of CXCR4 Antagonist AMD3100 on the Recruitment of Endogenous Endothelial Precursor Cells and Outcome of Stroke
. 2020;   Crossref logo
Link1 Link2

Antitumor effect of CXCR4 antagonist AMD3100 on the tumorigenic cell line of BHP10-3 papillary thyroid cancer cells
Head & Neck. 2016;38(10):1479-1486   Crossref logo
Link1 Link2

The CXCR4 antagonist AMD3100 impairs survival of human AML cells and induces their differentiation
Leukemia. 2008;22(12):2151-2158   Crossref logo
Link1 Link2 Link3

T134, a Small-Molecule CXCR4 Inhibitor, Has No Cross-Drug Resistance with AMD3100, a CXCR4 Antagonist with a Different Structure
Journal of Virology. 1999;73(2):1719-1723   Crossref logo
Link1 Link2

The CXCR4 antagonist AMD3100 suppresses hypoxia-mediated growth hormone production in GH3 rat pituitary adenoma cells
Journal of Neuro-Oncology. 2010;100(1):51-64   Crossref logo
Link1 Link2 Link3

Insights into the biology of mobilized hematopoietic stem/progenitor cells through innovative treatment schedules of the CXCR4 antagonist AMD3100
Experimental Hematology. 2009;37(3):402-415.e1   Crossref logo
Link1 Link2

Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100
Yearbook of Oncology. 2010;2010:128-129   Crossref logo
Link1 Link2

Recent advances on the use of the CXCR4 antagonist plerixafor (AMD3100, Mozobilâ„¢) and potential of other CXCR4 antagonists as stem cell mobilizers
Pharmacology & Therapeutics. 2010;128(3):509-518   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.